Mediterranean Towers Ltd. (MDTR.TA)
ILA 959.7
(1.07%)
ILA 959.7
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 240.79 Million | 234.29 Million | 213.09 Million | 206.63 Million | 195.35 Million | 174.5 Million |
| Cost of Revenue | 140.41 Million | 150.69 Million | 142.86 Million | 135.63 Million | 130.62 Million | 116.19 Million |
| Gross Profit | 100.37 Million | 83.59 Million | 70.23 Million | 71 Million | 64.73 Million | 58.31 Million |
| Operating Expenses | -312.72 Million | 58.31 Million | 54.15 Million | 35.96 Million | 47.28 Million | 40.91 Million |
| Selling, General and Administrative Expenses | 24.14 Million | 27.79 Million | 24.9 Million | 20.44 Million | 19.9 Million | 14.6 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -336.87 Million | -14.17 Million | -877 Thousand | -877 Thousand | -255 Thousand | 325 Thousand |
| Cost and Expenses | -172.31 Million | 209 Million | 197.02 Million | 171.59 Million | 177.91 Million | 157.1 Million |
| Operating Income | 413.1 Million | 324.34 Million | 517.05 Thousand | 20.79 Million | 183.91 Million | 155 Million |
| Interest Expense | 24.98 Million | 24.27 Million | 24.03 Million | 22.66 Million | 19.63 Million | 20.14 Million |
| Income Tax Expense | 76.86 Million | 31.55 Million | 105 Million | 2.64 Million | 45.17 Million | 39.29 Million |
| Earnings before Tax | 322.44 Million | 172.9 Million | 448.95 Million | -9.31 Million | 146.54 Million | 117.03 Million |
| Net Income | 220.57 Million | 120.91 Million | 296.67 Million | -12.74 Million | 81.1 Million | 62.72 Million |
| Earnings Per Share Basic | 1.47 | 0.80 | 1.98 | -0.08 | 0.55 | 0.44 |
| Earnings Per Share Diluted | 1.46 | 0.80 | 1.96 | -0.08 | 0.55 | 0.44 |
| Weighted Average Shares Outstanding | 150.39 Million | 150.31 Million | 150.06 Million | 150.03 Million | 146.39 Million | 143.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 151.16 Million | 151.32 Million | 151.12 Million | 150.57 Million | 146.73 Million | 143.96 Million |
| Gross Margin | 0.42 | 0.36 | 0.33 | 0.34 | 0.33 | 0.33 |
| EBIT Margin | 0.20 | 0.97 | 2.20 | 0.17 | 0.96 | 0.80 |
| Profit Margin | 0.92 | 0.52 | 1.39 | -0.06 | 0.42 | 0.36 |
| EBITDA | 47.42 Million | 27.56 Million | 17.13 Million | 25.16 Million | 18.6 Million | 19.44 Million |
| Earnings Before Tax Margin | 1.72 | 1.38 | 0.00 | 0.10 | 0.94 | 0.89 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 61.44 Million | 61.35 Million | 240.79 Million | 60.75 Million | 58.19 Million | 61.25 Million |
| Cost of Revenue | 31.52 Million | 29.9 Million | 140.41 Million | 31.41 Million | 33.96 Million | 39.03 Million |
| Gross Profit | 29.91 Million | 31.45 Million | 100.37 Million | 29.33 Million | 24.23 Million | 22.22 Million |
| Operating Expenses | 12.41 Million | 12.73 Million | 52.35 Million | 12.33 Million | 13.4 Million | 13.83 Million |
| Selling, General and Administrative Expenses | 12.41 Million | 12.73 Million | - | -15.88 Million | 13.4 Million | 13.83 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 162 Thousand | 259 Thousand | -2.25 Million | -1.04 Million | - | 783 Thousand |
| Cost and Expenses | 43.94 Million | 42.64 Million | 192.76 Million | 43.75 Million | 47.37 Million | 52.86 Million |
| Operating Income | 85.54 Million | 85.73 Million | 413.1 Million | 155.67 Million | 35.95 Million | 102.38 Million |
| Interest Expense | 45.76 Million | 14.18 Million | 24.98 Million | -66.2 Million | 21.79 Million | 38.05 Million |
| Income Tax Expense | 8.39 Million | 14.46 Million | 76.86 Million | 31.77 Million | 6.18 Million | 17.23 Million |
| Earnings before Tax | 44.08 Million | 76.27 Million | 322.44 Million | 147.64 Million | 15.5 Million | 68.19 Million |
| Net Income | 27.27 Million | 54.31 Million | 220.57 Million | 109.13 Million | 7.54 Million | 47.76 Million |
| Earnings Per Share Basic | 0.18 | 0.36 | - | 0.73 | 0.05 | 0.32 |
| Earnings Per Share Diluted | 0.18 | 0.36 | - | 0.71 | 0.05 | 0.32 |
| Weighted Average Shares Outstanding | 151.52 Million | 150.86 Million | 150.39 Million | 152.68 Million | 150.39 Million | 149.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 151.52 Million | 150.86 Million | 151.16 Million | 152.85 Million | 150.9 Million | 149.26 Million |
| Gross Margin | 0.49 | 0.51 | 0.42 | 0.48 | 0.42 | 0.36 |
| EBIT Margin | 1.47 | 1.48 | - | 1.34 | 0.64 | 1.60 |
| Profit Margin | 0.44 | 0.89 | 0.92 | 1.80 | 0.13 | 0.78 |
| EBITDA | 90.03 Million | 90.65 Million | - | 81.55 Million | 37.53 Million | 98.03 Million |
| Earnings Before Tax Margin | 1.39 | 1.40 | 1.72 | 2.56 | 0.62 | 1.67 |
RITM-PA
138A
R4
ORCHPHARMA
SKHCF
CDGLY